Evidence-Based Benefits
- Bone health — a 2013 RCT by Knapen et al. (n=244 postmenopausal women) found MK-7 at 180 mcg/day for 3 years significantly reduced age-related bone loss at the lumbar spine and femoral neck, and improved bone strength indices
- Cardiovascular protection — K2 activates matrix Gla protein (MGP), the most potent known inhibitor of vascular calcification; the Rotterdam Study (2004, n=4,807) found high dietary K2 intake was associated with 52% lower risk of severe aortic calcification and 57% lower cardiovascular mortality over 10 years
- Synergy with vitamin D3 — vitamin D increases calcium absorption, while K2 ensures that calcium is deposited in bones rather than accumulating in arteries; this combination may reduce the cardiovascular risk sometimes associated with calcium supplementation
- Dental health — osteocalcin activation by K2 supports dentin mineralization and may reduce cavity formation; K2-dependent proteins are expressed in dental tissues